Cargando…
Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells
INTRODUCTION: This study aims to develop a novel co-delivery gefitinib and quercetin system loaded with PLGA-PEG nanoparticles and evaluate their antitumor activity in vitro and in vivo. METHODS: Gef/Qur NPs were prepared and characterized. The release of drugs, stability, cellular uptake and cytoto...
Autores principales: | Shen, Yuzhou, TanTai, Jicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591005/ https://www.ncbi.nlm.nih.gov/pubmed/33122893 http://dx.doi.org/10.2147/DDDT.S275123 |
Ejemplares similares
-
Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network
por: Shen, Yuzhou, et al.
Publicado: (2014) -
Retraction Note: Ranking candidate genes of esophageal squamous cell carcinomas based on differentially expressed genes and the topological properties of the co-expression network
por: Shen, Yuzhou, et al.
Publicado: (2015) -
TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells
por: Tantai, Jicheng, et al.
Publicado: (2022) -
Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7
por: Pan, Xufeng, et al.
Publicado: (2019) -
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
por: Chen, Daoyuan, et al.
Publicado: (2023)